Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Irvine, CA
SEC filing record 1 source field available
Fiscal year end
31 December
Eledon Pharmaceuticals, Inc. has filed 607 SEC EDGAR filings since 18 Jun 2007

SEC filing history

Showing 301-325 of 604 matching filings.

Per page
25
Current page
13
PRE 14A File 001-36620

PRE 14A

Filing date
16 Mar 2020
Reporting date
12 May 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Feb 2020
Reporting date
14 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

4 filing

Filing date
25 Feb 2020
Reporting date
14 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-88334

AMENDMENT NO. 3

Filing date
25 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K/A File 001-36620

8-K/A

Filing date
20 Feb 2020
Reporting date
13 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
19 Feb 2020
Reporting date
13 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

SC 13G/A filing

Filing date
14 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88334

AMENDMENT NO. 1 TO THE SCHEDULE 13G

Filing date
13 Feb 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K - NASDAQ DELISTING

Filing date
07 Feb 2020
Reporting date
06 Feb 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
D File 021-359033

D filing

Filing date
27 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-232011

424B3

Filing date
16 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
16 Jan 2020
Reporting date
10 Jan 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
424B3 File 333-232011

424B3

Filing date
14 Jan 2020
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K Q3 2019 EARNINGS RELEASE

Filing date
13 Nov 2019
Reporting date
13 Nov 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
26 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
26 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
30 Sep 2019
Reporting date
26 Sep 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
13 Aug 2019
Reporting date
13 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-36620

Q2-2019 FORM 10-Q

Filing date
13 Aug 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
8-K File 001-36620

8-K

Filing date
09 Aug 2019
Reporting date
08 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G File 005-88334

SCHEDULE 13G DATED JULY 16, 2019

Filing date
26 Jul 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2019
Reporting date
11 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
15 Jul 2019
Reporting date
11 Jul 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .